Policy & Regulation

Australia: Finally, unproven stem cell clinic practices might be curtailed

28-10-17

Ethics & Society Policy & Regulation

ISSCR Responds to FDA Announcement of Enforcement Direction

29-08-17

Policy & Regulation Stem Cell News

REGenableMED Special Report

30-08-17

Policy & Regulation

• EuroStemCell resource

REGenableMED Project Synopsis

Ethics & Society Policy & Regulation

Stem Cell Tourism: Experts call for tighter regulation

05-07-17

Clinical Trials Ethics & Society

Regulation of stem cell research in Europe

Policy & Regulation

Regulation of stem cell research in the United Kingdom

18-07-17

Policy & Regulation

Ethics to Hype: How Media Frames Regenerative Medicine

06-02-17

Ethics & Society Policy & Regulation

Policy Briefings: Regenerative medicine, industry and clinical translation

Clinical Trials Policy & Regulation

ISSCR releases new global guidelines for stem cell research

Clinical Trials Policy & Regulation

'Embryonic Stem Cell Patents Banned': Theory of Knowledge

11-04-12

Embryonic Stem Cells Ethics & Society

Regenerative medicine and regulation: what’s GMP got to do with it?

05-07-17

Policy & Regulation Stem Cells & Industry

Browse our libraries by:

Theme

Condition

Type

Browse by:

Theme

Condition

Type

Policy & Regulation

Australia: Finally, unproven stem cell clinic practices might be curtailed

ISSCR Responds to FDA Announcement of Enforcement Direction

REGenableMED Special Report

REGenableMED Project Synopsis

Stem Cell Tourism: Experts call for tighter regulation

Regulation of stem cell research in Europe

Regulation of stem cell research in the United Kingdom

Ethics to Hype: How Media Frames Regenerative Medicine

Policy Briefings: Regenerative medicine, industry and clinical translation

ISSCR releases new global guidelines for stem cell research

'Embryonic Stem Cell Patents Banned': Theory of Knowledge

Regenerative medicine and regulation: what’s GMP got to do with it?